Solution for tissue adhesion prevention and method for tissue adhesion prevention
The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid.
1. The method for tissue adhesion prevention, comprising:
locally applying a solution comprising alpha, alpha-trehalose to living tissues exposed to air during surgery, wherein the solution for tissue adhesion prevention comprises alpha, alpha-trehalose in an amount effective to provide a cell membrane phospholipid-protecting effect and to prevent tissue adhesion following the surgery.
2. The method for tissue adhesion prevention according to claim 1 , wherein said solution for tissue adhesion prevention further comprises at least one selected from the group consisting of an antioxidant, a chelate, an antiseptic, a hemostatic, an anti-inflammatory agent, a polysaccharide, a mucopolysaccharide, a salt of a polysaccharide, and a salt of a mucopolysaccharide having a lubricating property.
3. The method for tissue adhesion prevention according to claim 2 , wherein said antioxidant is a derivative of ascorbic acid.
4. The method for tissue adhesion prevention according to claim 1 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener.
5. The method for tissue adhesion prevention according to claim 1 , wherein an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from the group consisting of an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, and water.
6. The method for tissue adhesion prevention according to claim 1 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener and an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from the group consisting of an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, and water.
7. The method for tissue adhesion prevention according to claim 1 , wherein said solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
8. The method for tissue adhesion prevention according to claim 1 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
9. The method for tissue adhesion prevention according to claim 1 , wherein an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from the group consisting of an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, and water, and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
10. The method for tissue adhesion prevention according to claim 1 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener, and an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from the group consisting of an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, and water, and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
11. The method for tissue adhesion prevention according to claim 2 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener.
12. The method for tissue adhesion prevention according to claim 3 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener.
13. The method for tissue adhesion prevention according to claim 2 , wherein an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water.
14. The method for tissue adhesion prevention according to claim 3 , wherein an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water.
15. The method for tissue adhesion prevention according to claim 2 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener and an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water.
16. The method for tissue adhesion prevention according to claim 3 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener and an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water.
17. The method for tissue adhesion prevention according to claim 2 , wherein said solution for tissue adhesion prevention is a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
18. The method for tissue adhesion prevention according to claim 2 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
19. The method for tissue adhesion prevention according to claim 2 , wherein an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water, and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
20. The method for tissue adhesion prevention according to claim 2 , wherein a viscosity of the solution for tissue adhesion prevention is adjusted by a thickener, and an osmolarity of the solution for tissue adhesion prevention is adjusted by at least one selected from an isotonic electrolyte fluid, a plasma expander, an extracellular replacement fluid, a maintenance fluid, or water, and the solution for tissue adhesion prevention is in a form of a perfusion fluid, a spray fluid, a solution for spray or vaporization administration, an aerosol preparation, an injection solution for intravenous fluids, or an intravenous fluid.
21. The method for tissue adhesion prevention according to claim 1 , wherein the surgery is chosen from laparotomy, thoracotomy, neurosurgery, orthopedic surgery, hepatic surgery, and gynecologic surgery.